Chief Scientific Officer · RECURSION PHARMACEUTICALS, INC. · Class A Common Stock
Side
F
Value
$81K
Shares
26.7K
Price
$3.04
Executed
May 15, 2026
Disclosed
May 19, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 15 executedMay 19, 2026 disclosed
RXRX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+4 / 25
$81K reported value · 2.6% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hallett David filed this Form 4 reporting a tax withholding of RXRX on May 15, 2026. It became public on May 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Hallett Davidcik:0002006495
Issuer
RECURSION PHARMACEUTICALS, INC.cik:0001601830
Revision history · 0
No field has changed since this record was first ingested.
